These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


232 related items for PubMed ID: 11141675

  • 21. The Carpentier-Edwards supra-annular porcine bioprosthesis: new generation low pressure glutaraldehyde fixed prosthesis.
    Jamieson WR, Munro AI, Miyagishima RT, Allen P, Janusz MT, Gerein AN, Burr LH, Ling H, Hayden RI, Tutassura H.
    J Card Surg; 1988 Dec; 3(4):507-21. PubMed ID: 2980055
    [Abstract] [Full Text] [Related]

  • 22. Long-term results of the Medtronic Mosaic porcine bioprosthesis in the aortic position.
    Anselmi A, Flécher E, Ruggieri VG, Harmouche M, Langanay T, Corbineau H, Verhoye JP, Leguerrier A.
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1884-91. PubMed ID: 23988288
    [Abstract] [Full Text] [Related]

  • 23. Twenty-year experience with the St. Jude medical Biocor bioprosthesis in the aortic position.
    Eichinger WB, Hettich IM, Ruzicka DJ, Holper K, Schricker C, Bleiziffer S, Lange R.
    Ann Thorac Surg; 2008 Oct; 86(4):1204-10. PubMed ID: 18805161
    [Abstract] [Full Text] [Related]

  • 24. The Toronto root stentless valve in the subcoronary position is hemodynamically superior to the mosaic stented completely supra-annular bioprosthesis.
    Bleiziffer S, Eichinger WB, Wagner I, Guenzinger R, Bauernschmitt R, Lange R.
    J Heart Valve Dis; 2005 Nov; 14(6):814-21; discussion 821. PubMed ID: 16359064
    [Abstract] [Full Text] [Related]

  • 25. Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age.
    Christ T, Grubitzsch H, Claus B, Konertz W.
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):264-9. PubMed ID: 23158257
    [Abstract] [Full Text] [Related]

  • 26. The Freedom Solo pericardial stentless valve: Single-center experience, outcomes, and long-term durability.
    Stanger O, Bleuel I, Gisler F, Göber V, Reineke S, Gahl B, Aymard T, Englberger L, Carrel T, Tevaearai H.
    J Thorac Cardiovasc Surg; 2015 Jul; 150(1):70-7. PubMed ID: 25769775
    [Abstract] [Full Text] [Related]

  • 27. Benefits and medium-term outcome of the Sorin Pericarbon Freedom stentless aortic prosthesis in cases of acute bacterial endocarditis.
    Stefanelli G, Pirro F, Meli M, Trevisan D, Telesca M, Campisano B, Mussini C, Barbieri A.
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):593-8. PubMed ID: 27255294
    [Abstract] [Full Text] [Related]

  • 28. Eleven years' experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with long-term relative survival rate.
    Dellgren G, Eriksson MJ, Brodin LA, Rådegran K.
    Eur J Cardiothorac Surg; 2002 Dec; 22(6):912-21. PubMed ID: 12467813
    [Abstract] [Full Text] [Related]

  • 29. Aortic Carpentier-Edwards supraannular porcine bioprosthesis: a 12-year experience.
    Logeais Y, Langanay T, Leguerrier A, Rioux C, Chaperon J, Coutté MB.
    Ann Thorac Surg; 1999 Aug; 68(2):421-5. PubMed ID: 10475406
    [Abstract] [Full Text] [Related]

  • 30. Safety, efficacy, and hemodynamic performance of a stented bovine pericardial aortic valve bioprosthesis: Two-year analysis.
    Dagenais F, Moront MG, Brown WM, Reardon MJ, Chu MWA, Gearhart E, Klautz RJM.
    J Thorac Cardiovasc Surg; 2020 Aug; 160(2):371-381.e4. PubMed ID: 31590957
    [Abstract] [Full Text] [Related]

  • 31. [The Sorin pericardial bioprosthesis--a stentless aortic valve with very good hemodynamic performance].
    Gegouskov VA, Eckstein FS, Kipfer B, Berdat PA, Immer FF, Schmidli J, Seiler C, Zobrist C, Carrel TP.
    Swiss Surg; 2003 Aug; 9(5):247-52. PubMed ID: 14601329
    [Abstract] [Full Text] [Related]

  • 32. Hemodynamic Performance and Durability of Mosaic Bioprostheses for Aortic Valve Replacement, up to 13 Years.
    Matsumoto Y, Fujita T, Hata H, Shimahara Y, Sato S, Kobayashi J.
    Circ J; 2015 Aug; 79(5):1044-51. PubMed ID: 25740500
    [Abstract] [Full Text] [Related]

  • 33. The Stentless Cryo-Life O'Brien porcine aortic valve at 10 years.
    Hvass U, Baron F, Elsebaey A, Nguyen D, Flecher E.
    J Heart Valve Dis; 2004 Nov; 13(6):977-83; discussion 983. PubMed ID: 15597593
    [Abstract] [Full Text] [Related]

  • 34. The Freedom SOLO valve for aortic valve replacement: clinical and hemodynamic results from a prospective multicenter trial.
    Beholz S, Repossini A, Livi U, Schepens M, El Gabry M, Matschke K, Trivedi U, Eckel L, Dapunt O, Zamorano JL.
    J Heart Valve Dis; 2010 Jan; 19(1):115-23. PubMed ID: 20329497
    [Abstract] [Full Text] [Related]

  • 35. Echocardiographic assessment and preliminary clinical results after aortic valve replacement with the Medtronic Mosaic bioprosthesis.
    Corbineau H, Lelong B, Langanay T, Verhoye JP, Leguerrier A.
    J Heart Valve Dis; 2001 Mar; 10(2):171-6. PubMed ID: 11297203
    [Abstract] [Full Text] [Related]

  • 36. Carpentier-Edwards standard porcine bioprosthesis: clinical performance to seventeen years.
    Jamieson WR, Munro AI, Miyagishima RT, Allen P, Burr LH, Tyers GF.
    Ann Thorac Surg; 1995 Oct; 60(4):999-1006; discussion 1007. PubMed ID: 7575007
    [Abstract] [Full Text] [Related]

  • 37. Survival after stentless and stented xenograft aortic valve replacement: a concurrent, controlled trial.
    Luciani GB, Casali G, Auriemma S, Santini F, Mazzucco A.
    Ann Thorac Surg; 2002 Nov; 74(5):1443-9. PubMed ID: 12440591
    [Abstract] [Full Text] [Related]

  • 38. Clinical outcomes after aortic valve replacement with the Toronto stentless porcine valve.
    Goldman BS, David TE, Wood JR, Pepper JR, Goldman SM, Verrier ED, Petracek MR.
    Ann Thorac Surg; 2001 May; 71(5 Suppl):S302-5. PubMed ID: 11388210
    [Abstract] [Full Text] [Related]

  • 39. Clinical experience with the ATS 3F stentless aortic bioprosthesis: five years' follow up.
    Linneweber J, Heinbokel T, Christ T, Claus B, Kossagk C, Konertz W.
    J Heart Valve Dis; 2010 Nov; 19(6):772-7. PubMed ID: 21214103
    [Abstract] [Full Text] [Related]

  • 40. Use of stentless xenografts in the aortic position: determinants of early and late outcome.
    Akar AR, Szafranek A, Alexiou C, Janas R, Jasinski MJ, Swanevelder J, Sosnowski AW.
    Ann Thorac Surg; 2002 Nov; 74(5):1450-7; discussion 1457-8. PubMed ID: 12440592
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.